Medtech: Ecosystems Win

Medtech competition—especially in structural heart—has shifted from selling a single device to owning a full procedural ecosystem that includes imaging, delivery tools, implants and post‑procedural monitoring. Analysts point to specific growth pockets such as renal denervation and say firms that assemble ecosystem assets will gain pricing power and account stickiness. ( )